An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer

Summary

This is a phase 2, multicenter, single arm, open-lable study of ICP-192. The purpose of this study is to evaluate efficacy of ICP-192 in subjects with surgically unresectable or metastatic bladder urothelial cancer.

Timeline

Start

2020-05-27

Primary completion

2024-12-31

Completion

2025-06-30

Drugs

Indications